{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:36Z","timestamp":1771545636604,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s15006-026-5639-y","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:02:39Z","timestamp":1771542159000},"page":"56-63","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antiresorptive Therapie:  Cave Kiefernekrose!","Jaw necrosis under  antiresorptive osteoporosis therapy"],"prefix":"10.1007","volume":"168","author":[{"given":"Katharina Theresa","family":"Obermeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Otto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ina","family":"Dewenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Adler Reichel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Drey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"W\u00fcrstlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Hesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa","family":"Feist-Pagenstert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Schmidmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"5639_CR4957","doi-asserted-by":"crossref","unstructured":"H\u00e4ndel MN et al. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ. 2023;381:e068033","DOI":"10.1136\/bmj-2021-068033"},{"key":"5639_CR4961","doi-asserted-by":"crossref","unstructured":"Khosla S et al. Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5:898-907","DOI":"10.1016\/S2213-8587(17)30188-2"},{"key":"5639_CR4965","doi-asserted-by":"crossref","unstructured":"Jiang A et al. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies. Arch Toxicol. 2024;98:689-708","DOI":"10.1007\/s00204-023-03653-7"},{"key":"5639_CR4969","doi-asserted-by":"crossref","unstructured":"Ruggiero SL et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014;72:1938-56","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"5639_CR4973","doi-asserted-by":"crossref","unstructured":"Maluf G et al. A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants. Int J Implant Dent. 2019;5:34","DOI":"10.1186\/s40729-019-0188-0"},{"key":"5639_CR4977","doi-asserted-by":"crossref","unstructured":"Thomasius F et al. Clinical Practice Guideline: The Diagnosis and Treatment of Osteoporosis. Dtsch Arztebl Int. 2025;122:12-8","DOI":"10.3238\/arztebl.m2024.0222"},{"key":"5639_CR4981","doi-asserted-by":"crossref","unstructured":"Watts NB et al. Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years. J Clin Endocrinol Metab. 2019;104:2443-52","DOI":"10.1210\/jc.2018-01965"},{"key":"5639_CR5109","doi-asserted-by":"crossref","unstructured":"Tran T et al. Association of Multimorbidity and Excess Mortality After Fractures Among Danish Adults. JAMA Netw Open. 2022;5:e2235856","DOI":"10.1001\/jamanetworkopen.2022.35856"},{"key":"5639_CR5113","doi-asserted-by":"crossref","unstructured":"Bergh C et al. 30-day and 1-year mortality after skeletal fractures: a register study of 295,713 fractures at different locations. Acta Orthop. 2021;92:739-45","DOI":"10.1080\/17453674.2021.1959003"},{"key":"5639_CR5117","doi-asserted-by":"crossref","unstructured":"Johansson L et al. Decreased physical health-related quality of life-a persisting state for older women with clinical vertebral fracture. Osteoporos Int. 2019;30:1961-71","DOI":"10.1007\/s00198-019-05044-0"},{"key":"5639_CR5121","doi-asserted-by":"crossref","unstructured":"Stanghelle B et al. Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture. BMC Geriatr. 2019;19:298","DOI":"10.1186\/s12877-019-1268-y"},{"key":"5639_CR5125","doi-asserted-by":"crossref","unstructured":"Klop C et al. Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. 2014;66:171-7","DOI":"10.1016\/j.bone.2014.06.011"},{"key":"5639_CR5129","doi-asserted-by":"crossref","unstructured":"Dyer SM et al. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr. 2016;16:158","DOI":"10.1186\/s12877-016-0332-0"},{"key":"5639_CR4985","doi-asserted-by":"crossref","unstructured":"Hadji P et al. Gender- and age-related treatment compliance in patients with osteoporosis in Germany. Patient Prefer Adherence. 2016;10:2379-85","DOI":"10.2147\/PPA.S118396"},{"key":"5639_CR4989","unstructured":"DGMKG \u2013 Deutsche Gesellschaft f\u00fcr Mund-, Kiefer- und Gesichtschirurgie. S3-Leitlinie: Antiresorptiva-assoziierte Kiefernekrosen \u2013 Diagnostik, Therapie und Pr\u00e4vention. AWMF-Registernummer: 007-091, Stand: 2021. Verf\u00fcgbar unter: https:\/\/register.awmf.org\/de\/leitlinien\/detail\/007-091; abgerufen am 19.01.2026"},{"key":"5639_CR4993","doi-asserted-by":"crossref","unstructured":"Otto S et al. The role of inferior alveolar nerve involvement in bisphosphonate-related osteonecrosis of the jaw. J Oral Maxillofac Surg. 2009;67:589-92","DOI":"10.1016\/j.joms.2008.09.028"},{"key":"5639_CR4997","doi-asserted-by":"crossref","unstructured":"Otto S et al. Bisphosphonate-related osteonecrosis of the jaw: is pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg. 2010;68:1158-61","DOI":"10.1016\/j.joms.2009.07.079"},{"key":"5639_CR5003","doi-asserted-by":"crossref","unstructured":"Khan AA et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 2015;30:3-23","DOI":"10.1002\/jbmr.2405"},{"key":"5639_CR5009","doi-asserted-by":"crossref","unstructured":"Obermeier KT et al. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw. Sci Rep. 2024;14:7914","DOI":"10.1038\/s41598-024-57635-5"},{"key":"5639_CR5013","doi-asserted-by":"crossref","unstructured":"Akashi M et al. A literature review of perioperative antibiotic administration in surgery for medication-related osteonecrosis of the jaw. Oral Maxillofac Surg. 2018;22:369-78","DOI":"10.1007\/s10006-018-0732-8"},{"key":"5639_CR5019","doi-asserted-by":"crossref","unstructured":"Hasegawa T et al. The observational study of delayed wound healing after tooth extraction in patients receiving oral bisphosphonate therapy. J Craniomaxillofac Surg. 2013;41:558-63","DOI":"10.1016\/j.jcms.2012.11.023"},{"key":"5639_CR5023","unstructured":"Schiegnitz E et al. S3-Leitlinie Antiresorptiva-assoziierte Kiefernekrosen (AR-ONJ). AWMF-Register-Nr. 007-091"},{"key":"5639_CR5027","unstructured":"Bonacina R et al. Preventive strategies and clinical implications for bisphosphonate-related osteonecrosis of the jaw: a review of 282 patients. J Can Dent Assoc. 2011;77:b147"},{"key":"5639_CR5033","doi-asserted-by":"crossref","unstructured":"Bodem JP et al. Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction. J Craniomaxillofac Surg. 2015;43:510-4","DOI":"10.1016\/j.jcms.2015.02.018"},{"key":"5639_CR5052","doi-asserted-by":"crossref","unstructured":"Nakamura T et al. Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study). Osteoporos Int. 2017;28:389-98","DOI":"10.1007\/s00198-016-3736-y"},{"key":"5639_CR5059","doi-asserted-by":"crossref","unstructured":"Otto S et al. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series. J Oral Implantol. 2023;49:39-45","DOI":"10.1563\/aaid-joi-D-21-00035"},{"key":"5639_CR5064","unstructured":"Gr\u00f6tz KA et al. Zahnimplantate bei medikament\u00f6ser Behandlung mit Knochenantiresorptiva (inkl. Bisphosphonate). AWMF-Registernummer: 083-026, Stand: Juli 2016"},{"key":"5639_CR5068","doi-asserted-by":"crossref","unstructured":"Cosman F et al. Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses. J Bone Miner Res. 2022;37:2112-20","DOI":"10.1002\/jbmr.4705"},{"key":"5639_CR5074","doi-asserted-by":"crossref","unstructured":"Sher J et al. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review. J Oral Implantol. 2021;47:249-68","DOI":"10.1563\/aaid-joi-D-19-00351"},{"key":"5639_CR5197","doi-asserted-by":"crossref","unstructured":"Otto S et al. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Medicina (Kaunas). 2021;57:463","DOI":"10.3390\/medicina57050463"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-026-5639-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5639-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:02:42Z","timestamp":1771542162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-026-5639-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5639"],"URL":"https:\/\/doi.org\/10.1007\/s15006-026-5639-y","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"20 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Die Autoren erkl\u00e4ren, dass sie sich bei der Erstellung des Beitrages von keinen wirtschaftlichen Interessen leiten lie\u00dfen. Sie legen folgende potenzielle Interessenkonflikte offen: keine.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag erkl\u00e4rt, dass die inhaltliche Qualit\u00e4t des Beitrags durch zwei unabh\u00e4ngige Gutachten best\u00e4tigt wurde. Werbung in dieser Zeitschriftenausgabe hat keinen Bezug zur CME-Fortbildung.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Der Verlag garantiert, dass die CME-Fortbildung sowie die CME-Fragen frei sind von werblichen Aussagen und keinerlei Produktempfehlungen enthalten. Dies gilt insbesondere f\u00fcr Pr\u00e4parate, die zur Therapie des dargestellten Krankheitsbildes geeignet sind.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}